AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Transaction in Own Shares Oct 17, 2023

7581_rns_2023-10-17_4de55e2a-dea1-4c1b-a51e-a69f726cdc1c.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3896Q

Craneware plc

17 October 2023

Craneware plc

("Craneware" or the "Company" or the "Group")

Extension of share buyback programme

17 October 2023 - Craneware (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, is pleased to announce its decision to extend the share buyback programme, originally due to expire on 17 October 2023, for a further three months to 17 January 2024, under the same terms as previously announced.

For further information, please contact:

Craneware plc                                                                                      +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR)                                                                             +44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon                                      [email protected]

Peel Hunt (NOMAD and Joint Broker)                                                   +44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

Investec Bank PLC (Joint Broker)                                                         +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSEAPEXFLDDFEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.